MS-OMICS ApSActive
Key figures
16.799.037 kr.-3,9%
Gross profit 2025
+37,2%
Average annual growth 2020–2025
Key ratios
20257.034.173 kr.
EBITDA
17,5%
Equity ratio
0,9×
Current ratio
25,5%
Return on equity
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
Corporate tax
income year 2021The company is jointly taxed. Tax is assessed collectively at the administration company Clinical-Microbiomics A/S.
2021Taxable income 0 kr.Losses deducted 151.858 kr.0 kr.
2020Taxable income -1.535.294 kr.0 kr.
2019Taxable income -894.790 kr.0 kr.
Corporate tax →
Source: the Danish Tax Agency's public company tax lists. Calculated tax for the income year; may be lower than 22% of income, e.g. when tax is paid abroad. sktst.dk
Financial statements2017–2025
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||
| Cash and cash equivalents | 85.000 | 79.304 | 303.346 | 1.319.993 | 402.150 | 1.171.171 | 61.661 | 1.075.662 | 258.622 |
| Total current assets | 624.000 | 816.492 | 1.259.304 | 2.649.213 | 2.764.596 | 4.567.760 | 5.544.518 | 6.688.716 | 9.877.322 |
| Total non-current assets | 331.000 | 4.921.679 | 5.138.286 | 8.399.089 | 8.197.366 | 15.375.357 | 13.146.587 | 12.406.346 | 8.260.018 |
| Total assets | 955.000 | 5.738.171 | 6.397.590 | 11.048.302 | 10.961.962 | 19.943.117 | 18.691.105 | 19.095.062 | 18.137.340 |
| Balance sheet — liabilities and equity | |||||||||
| Current liabilities | 639.000 | 957.217 | 1.380.263 | 3.599.446 | 3.717.470 | 10.566.150 | 12.443.290 | 12.040.351 | 11.293.170 |
| Non-current liabilities | 907.000 | 4.317.775 | 4.599.380 | 7.798.215 | 7.174.477 | 9.778.677 | 6.226.197 | 4.691.352 | 3.011.596 |
| Total liabilities | 1.546.000 | 5.274.992 | 5.979.643 | 11.397.661 | 10.891.947 | 20.344.827 | 18.669.487 | 16.731.703 | 14.304.766 |
| Share capital | 50.000 | 71.390 | 71.390 | 76.390 | 76.390 | 76.390 | 76.390 | 76.390 | 76.390 |
| Retained earnings of previous periods | -641.000 | -1.586.821 | -502.307 | -1.727.926 | -1.186.199 | -1.448.819 | -792.820 | 1.439.314 | 2.069.841 |
| Profit for the year | 146.000 | -945.431 | -45.231 | -1.267.307 | 419.374 | -155.271 | 423.328 | 2.341.741 | 806.990 |
| Total equity | -591.000 | 463.179 | 417.947 | -349.359 | 70.015 | -401.710 | 21.618 | 2.363.359 | 3.170.348 |
| Income statement | |||||||||
| Gross profit | — | — | — | 3.453.855 | 7.341.503 | 10.713.930 | 15.391.185 | 17.473.765 | 16.799.037 |
| Operating profit | 217.000 | -772.454 | 235.668 | -896.256 | 858.000 | 578.214 | 1.594.922 | 3.127.779 | 2.724.403 |
| EBITDA | 262.000 | -438.773 | 937.445 | 96.916 | 2.378.563 | 3.281.603 | 5.786.449 | 7.568.561 | 7.034.173 |
| Profit before income tax | — | — | -45.231 | -1.267.307 | 419.374 | -246.997 | 448.378 | 2.199.414 | 1.955.521 |
| Profit for the reporting year | 146.000 | -945.431 | -45.231 | -1.267.307 | 419.374 | -155.271 | 423.328 | 2.341.741 | 806.990 |
| Labour costs | 749.000 | 1.737.842 | 1.708.247 | 3.281.557 | 4.962.940 | 7.432.327 | 9.604.736 | 9.905.204 | 9.764.864 |
| Depreciation of non-current assets | 45.000 | 333.681 | 701.777 | 993.172 | 1.520.563 | 2.703.389 | 4.191.527 | 4.440.782 | 4.309.770 |
| Other indicators | |||||||||
| Employees | 3 | 5 | 4 | 7 | 10 | 11 | 13 | 14 | 13 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.